BIND Therapeutics, Inc.

Company Listings from SPi: BIND Therapeutics, Inc.

You are here: Home >> SPi Company Listings >> BIND Therapeutics, Inc.

 

BIND Therapeutics, Inc.

Website:
http://

Search for other references to "bind" on SPi News

Latest BIND Therapeutics, Inc. News

BIND Therapeutics Announces Two Bidders Join Pfizer’s Stalking Horse Bid in Auction for BIND’s Assets BIND Therapeutics, Inc. (NASDAQ:BIND), a biotechnology company developing targeted and programmable therapeutics called ACCURINS®, today announced that it ha...... 12:00 GMT Monday 25th July 2016

BIND Therapeutics Reports First Quarter 2016 Financial Results and Provides Business Update BIND Therapeutics, Inc. (NASDAQ:BIND), a clinical-stage nanomedicine company developing targeted and programmable therapeutics called ACCURINS®, today report...... 12:00 GMT Monday 9th May 2016

BIND Therapeutics Announces Collaboration with Affilogic to Provide BIND with Access to Targeting Ligands that are Key Modulators of Anti-tumor Immunity BIND Therapeutics, Inc. (NASDAQ: BIND), a biotechnology company developing targeted and programmable therapeutics called ACCURINS®, today announced a researc...... 13:00 GMT Thursday 5th May 2016

BIND Therapeutics to Report First Quarter 2016 Financial Results on May 9, 2016 BIND Therapeutics, Inc. (NASDAQ: BIND), a biotechnology company developing targeted and programmable therapeutics called ACCURINS®, today announced it will h...... 21:01 GMT Tuesday 3rd May 2016

BIND Therapeutics Initiates Voluntary Chapter 11 Bankruptcy Protection Proceeding BIND Therapeutics, Inc. (NASDAQ:BIND), a biotechnology company developing targeted and programmable therapeutics called ACCURINS®, today announced that it ha...... 11:00 GMT Monday 2nd May 2016

BIND Therapeutics to Present at JMP Securities Life Sciences Conference 2015 BIND Therapeutics, Inc. (NASDAQ: BIND), a clinical-stage nanomedicine company developing targeted and programmable therapeutics called AccurinsTM, announced t...... 13:00 GMT Tuesday 16th June 2015

Data from Three Abstracts Validating Potential of BIND Therapeutics’ Accurins™ to be Presented at American Association for Cancer Research Annual Meeting BIND Therapeutics, Inc. (NASDAQ: BIND), a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called Accurins, toda...... 20:23 GMT Wednesday 18th March 2015

BIND Therapeutics Announces Closing of Public Offering of Common Stock and Warrants to Purchase Common Stock BIND Therapeutics, Inc. (NASDAQ:BIND), a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called Accurins™, to...... 16:33 GMT Tuesday 10th February 2015

BIND Therapeutics Amends Credit Facility from Hercules Technology III, L.P. to Accelerate Accurin Pipeline Growth BIND Therapeutics, Inc. (NASDAQ: BIND), a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called AccurinsTM, an...... 22:00 GMT Friday 23rd January 2015

BIND Therapeutics Co-Founder Publishes Nanotechnology Article in the Journal of the American Medical Association BIND Therapeutics, Inc. (NASDAQ: BIND), a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called Accurins™, t...... 13:00 GMT Thursday 22nd January 2015

Buy BIND Therapeutics, Inc.
Market Reports
from SPi

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us